Sartorius held by DZ Bank as Berenberg lifts price target to €270

DZ Bank kept its rating on Sartorius at "Hold" and reaffirmed a fair value of €216 per share, noting that the company's second‑quarter results slightly beat market expectations and confirmed its recovery path despite tariff distortions.

Berenberg maintained its Buy recommendation with a €270 price target, pointing to accelerated growth in the bioprocessing and laboratory segments. The analyst highlighted a €26 million refund linked to U.S. import tariffs and planned compensation payments to customers for tariff surcharges, which together offset cost pressures and support the upbeat outlook.

Both reports underline that Sartorius is benefitting from a rebound in life‑science markets while navigating tariff‑related challenges.